Global Drugs for HIV Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Drugs for HIV Market Overview

1.1 Drugs for HIV Definition

1.2 Global Drugs for HIV Market Size Status and Outlook (2019-2032)

1.3 Global Drugs for HIV Market Size Comparison by Region (2019-2032)

1.4 Global Drugs for HIV Market Size Comparison by Type (2019-2032)

1.5 Global Drugs for HIV Market Size Comparison by Application (2019-2032)

1.6 Global Drugs for HIV Market Size Comparison by Sales Channel (2019-2032)

1.7 Drugs for HIV Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Drugs for HIV Market Snapshot

2.2 Global Drugs for HIV Market Volume & Revenue (2019-2025)

2.3 Global Drugs for HIV Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Drugs for HIV Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Drugs for HIV Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Drugs for HIV Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Drugs for HIV Market Segment Analysis by Player

3.1 Global Drugs for HIV Sales and Market Share by Player (2023-2025)

3.2 Global Drugs for HIV Revenue and Market Share by Player (2023-2025)

3.3 Global Drugs for HIV Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Drugs for HIV Market Segment Analysis by Type

4.1 Global Drugs for HIV Market by Type

4.1.1 Non-Nucleoside Reverse Transcriptase Inhibitors(NNRTIs)

4.1.2 Integrase Inhibitors

4.1.3 Combination HIV Medicines

4.1.4 Others

4.2 Global Drugs for HIV Sales and Market Share by Type (2019-2025)

4.3 Global Drugs for HIV Revenue and Market Share by Type (2019-2025)

4.4 Global Drugs for HIV Average Price by Type (2019-2025)

4.5 Leading Players of Drugs for HIV by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Drugs for HIV Market Segment Analysis by Application

5.1 Global Drugs for HIV Market by Application

5.1.1 Hospital Pharmacies

5.1.2 Retail Pharmacies

5.1.3 Online Pharmacies

5.1.4 Others

5.2 Global Drugs for HIV Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Drugs for HIV by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Drugs for HIV Market Segment Analysis by Sales Channel

6.1 Global Drugs for HIV Market by Sales Channel

6.1.1 Global Drugs for HIV Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Drugs for HIV Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Drugs for HIV Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Drugs for HIV by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Drugs for HIV Market Segment Analysis by Region

7.1 Global Drugs for HIV Market Size and CAGR by Region (2019-2032)

7.2 Global Drugs for HIV Sales and Market Share by Region (2019-2025)

7.3 Global Drugs for HIV Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Drugs for HIV Market Share by Type

7.4.3 North America Drugs for HIV Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Drugs for HIV Market Share by Type

7.5.3 Europe Drugs for HIV Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Drugs for HIV Market Share by Type

7.6.3 Asia-Pacific Drugs for HIV Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Drugs for HIV Market Share by Type

7.7.3 South America Drugs for HIV Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Drugs for HIV Market Share by Type

7.8.3 Middle East & Africa Drugs for HIV Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Drugs for HIV Players

8.1 ViiV Healthcare

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Gilead Sciences Inc

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Merck Sharp & Dohme Corp

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Bristol-Myers Squibb Company

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Janssen Pharmaceuticals Inc.

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Theratechnologies Inc.

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Mylan Pharmaceuticals Inc.

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Genentech Inc.

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 AbbVie Inc.

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Others

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Drugs for HIV

9.1 Industrial Chain of Drugs for HIV

9.2 Upstream of Drugs for HIV

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Drugs for HIV

9.3.1 Leading Distributors/Dealers of Drugs for HIV

9.3.2 Leading Consumers of Drugs for HIV

Chapter 10. Global Drugs for HIV Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Drugs for HIV Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Drugs for HIV Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Drugs for HIV (2026-2032)

11.1 Global Drugs for HIV Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Drugs for HIV Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Drugs for HIV Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Drugs for HIV Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Drugs for HIV Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Drugs for HIV Import-Export (2019-2025)

12.2 Europe Drugs for HIV Import-Export (2019-2025)

12.3 Asia Pacific Drugs for HIV Import-Export (2019-2025)

12.4 South America Drugs for HIV Import-Export (2019-2025)

12.5 Middle East & Africa Drugs for HIV Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Drugs for HIV Demand-Supply (2019-2025)

13.2 Europe Drugs for HIV Demand-Supply (2019-2025)

13.3 Asia Pacific Drugs for HIV Demand-Supply (2019-2025)

13.4 South America Drugs for HIV Demand-Supply (2019-2025)

13.5 Middle East & Africa Drugs for HIV Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources